Development of a TB vaccine trial site in Africa and lessons from the Ebola experience
Abstract Tuberculosis is the deadliest infection of our time. In contrast, about 11,000 people died of Ebola between 2014 and 2016. Despite this manifest difference in mortality, there is now a vaccine licensed in the United States and by the European Medicines Agency, with up to 100% efficacy again...
Saved in:
Main Authors: | G. Kaguthi (Author), V. Nduba (Author), P. Rabuogi (Author), D. Okelloh (Author), S. G. Ouma (Author), G. Blatner (Author), S. Gelderbloem (Author), Ellen M. H. Mitchell (Author), Cherise P. Scott (Author), S. Verver (Author), T. Hawkridge (Author), J. E. M. de Steenwinkel (Author), K. F. Laserson (Author), J. H. Richardus (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impact of the nurses', doctors' and clinical officer strikes on mortality in four health facilities in Kenya
by: Grace Kiringa Kaguthi, et al.
Published: (2020) -
Towards pharmacogenomics-guided tuberculosis (TB) therapy: N-acetyltransferase-2 genotypes among TB-infected Kenyans of mixed ethnicity
by: Lilian N. Njagi, et al.
Published: (2024) -
TB-related catastrophic costs in Ethiopia
by: A.A. Deribew, et al.
Published: (2024) -
The Ebola suspect's dilemma
by: Eugene T Richardson, et al.
Published: (2017) -
Influence of the 2014 West African Ebola epidemic on essential health service utilization in a Liberian district
by: R.Y.S. Wong, et al.
Published: (2016)